700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ ReadersThis Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Aim: This experiment evaluated the influence of erythropoietin in an animal model of uterine ischemia reperfusion using the quoting established protocol. The effects of erythropoietin treatment were evaluated by mean Endometrial Karyorrhexis (EK) lesions. Materials and methods: EK lesions were determined at the 60th reperfusion min (for groups A and C) and at the 120th reperfusion min (for groups B and D). Groups A and B received no drugs, whereas rats from groups C and D were administered with erythropoietin. 40 rats of mean mass 247.7 g were employed for the study. Results: Epo administration non-significantly decreased the EK scores by [without lesions] 0.4 [-0.9640457 - 0.1640457] (p = 0.1242). Reperfusion time nonsignificantly decreased the EK scores by [without lesions] 0.1 [-0.678208 - 0.478208] (P = 0.6729). However, Epo administration and reperfusion time together nonsignificantly decreased the EK scores by [without lesions] 0.2727273 [-0.6102818 - 0.0648273] (p = 0.1102). Conclusions: Epo administration whether it interacted or not with reperfusion time, non-significantly decreased the EK scores in a short-term context of 2 hours.
Ischemia, Erythropoietin, Endometrial karyorrhexis, Reperfusion, Contraceptives, Barrier Contraceptives, Behavioral Contraceptives, Birth Control, Contraception, Dual Protection Contraceptives, Emergency Contraceptives, Family Planning, Fertility Control, Hormonal Contraceptives, Implantable Contraceptives, Intrauterine Devices, Sex Education, Sexually Transmitted Infections, Sterilization, Tubal Ligation, Vasectomy, Reproductive Physiology, Prenatal Diagnosis